In Touch - Regulator rejects macular disease treatment; Optomap

Regulator rejects macular disease treatment; Optomap

Download Regulator rejects macular disease treatment; Optomap

The treatment of Geographic Atrophy (GA) or late stage dry age-related macular degeneration as it's also known, is proving to be a pretty tough nut to crack. Hopes had been high that a treatment available in the USA would also be approved for use here in the UK. However, the Medicines and Healthcare products Regulatory Agency (MHRA) has rejected the application. Ed Holloway, Chief Executive of the Macular Society and Bill Best who has lived with GA for many years join us to discuss the MHRA decision.

Optomap is an imaging system which produces significantly more detailed information about the retina than had been available before. This can lead to earlier diagnosis of many eye conditions and accordingly a better chance of preventing sight loss. Dr Peter Hampson, Policy and Clinical Director of the Association of Optometrists and John Hopcroft, Clinical Services Manager at Boots join us to discuss the system and how public access to it is being improved by bringing it to the high street.
Presenter: Peter White
Producer: Fern Lulham
Production Coordinator: David Baguley

Website image description: Peter White sits smiling in the centre of the image, wearing a dark green jumper. Above Peter's head is the BBC logo (three individual white squares house each of the three letters). Bottom centre and overlaying the image are the words "In Touch"; and the Radio 4 logo (the word Radio in a bold white font, with the number 4 inside a white circle). The background is a bright mid-blue with two rectangles angled diagonally to
the right. Both are behind Peter, one of a darker blue and the other is a lighter blue.’

Published on Tuesday, 28th January 2025.

Available Podcasts from In Touch

Subscribe to In Touch

We are not the BBC, we only list available podcasts. To find out more about the programme including episodes available on BBC iPlayer, go to the In Touch webpage.